Clinical trial NCT02237222: Evaluation of Gait Performance in Children With Neuromuscular Diagnoses
Official title: Evaluation of the Gait Performance Measures 'Functional Mobility Scale' and 'Gillette Functional Assessment Questionnaire' in Children With Neuromuscular Diagnoses
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Psychometrics of Two Translated Measurement Tools
Keywords: Outcome Assessment
Gait
Neuromuscular Diseases
Psychometrics
Clinical Assessment Tools
Lead sponsor: University Children's Hospital, Zurich
Sponsor class: OTHER
First posted: 2014-09-11
Enrollment: 72
Sex: ALL
Minimum age (years): 6
Maximum age (years): 18
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Children with neuromuscular diagnoses, who are inpatients in the rehabilitation center of the University Children's Hospital Zurich in Affoltern am Albis.

Brief summary: The aims of this project are to evaluate the psychometric properties of the German versions of the two performance questionnaires 'Functional Mobility Scale' (FMS) and 'Gillette Functional Assessment Questionnaire - walking scale' (GFAQ) in children between 6-18 years with a neuromuscular diagnosis.

Detailed description: The German versions of the two questionnaires 'Functional Mobility Scale' (FMS) and 'Gillette Functional Assessment Questionnaire - walking scale' (GFAQ) are evaluated in terms of construct validity, inter- and intra-rater reliability as well as responsiveness in children with a neuromuscular diagnosis, who absolve an inpatient stay in the rehabilitation center of the University Chilren's Hospital Zurich, Switzerland.

Eligibility criteria: Inclusion Criteria:

* Neuromuscular diagnosis
* Age: 6-18 years
* Rehabilitation goal = improvement of walking abilities

Exclusion Criteria:

* Children's whose parents are not German-speaking

Primary outcomes:
measure: Functional Mobility Scale (FMS)
timeFrame: Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with measurements at admission and discharge.
measure: Gillette Functional Assessment Questionnaire - Walking Scale (GFAQ)
timeFrame: Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with measurements at admission and discharge.
Secondary outcomes:
measure: Global Rating Scale (GRS)
timeFrame: Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with only one measurement at discharge.
Other outcomes:
measure: Functional Independence Measure for Children (WeeFIM)
timeFrame: Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with measurements at admission and discharge.
measure: 10-Meter Walk Test (10MWT)
timeFrame: Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with only one measurement at discharge.
measure: 6-Minute walk test (6MinWT)
timeFrame: Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with only one measurement at discharge.
Locations:
city: Affoltern am Albis
country: Switzerland
facility: University Children's Hospital Zurich, Rehabilitation Center
Study officials:
affiliation: University Children's Hospital Zurich, Rehabilitation Center Affoltern
name: Corinne Ammann-Reiffer, MPTSc
role: PRINCIPAL_INVESTIGATOR
References: